SYMBOL: OTCQB: MBAIF; CSE: MbAI
- Outstanding Shares: 100,949,668 (as of 11/27/2023)
- Float: 20,977,663 (as of 05/26/2023)
- medbright.ai
MedBright AI is a capital allocator focused on investing in healthcare technology companies.
MedBright’s mission is to construct a portfolio of synergistic investments that generate superior returns for shareholders. The company’s strategic investments combine to create a leading AI-platform, MedMatrix, with trained models powered by machine learning to continuously learn and create operational efficiencies in the healthcare space.
Solving the $200B Healthcare Resource Matching Problem
- Long wait times to get a scheduled appointment with a doctor
- Sitting in a waiting room for 30+ minutes
- Seeing a doctor who cannot adequately treat your symptoms
The solution: Use AI-powered data analytics to dynamically prioritize and schedule patients based on needs, improving clinic revenue, patient satisfaction and physician burnout.
Introducing MedBright’s Flagship Product
The MedMatrix platform helps doctors find hidden value in their clinics, and improve both patient and physician satisfaction. MedMatrix is a virtual clinic resource manager, predicting personalized patient needs and seamlessly matching resources to meet them.
How MedMatrix Works
First Mover in Massive Market
US Healthcare Market is one of the largest single markets in the world
The MedMatrix initial target market of US-based outpatient services represents $660B in annual spend, with the total market including hospitals representing $2.2T.
Healthcare Services
$2.2 Trillion
Resource Matching is a Traditionally Ignored Problem
Technology solutions have focused on digital transformation of healthcare records and diagnostic capabilities, not on operational overhead. The complexity of scheduling could not be solved previously without new technology breakthroughs in AI and predictive analytics.
US Healthcare Administrative Overhead Spend
$1 Trillion
Technology is ready for immediate commercialization
MedMatrix has near term clinic funnel of over $100M, with technology that is ready for production today.
Outpatient Services
$660 Billion
Go To Market Playbook
An in-clinic optimization platform for doctors
Capture small to medium sized clinics ($10-$20M/yr revenue)
Goal to have $100-$150M of clinic revenue using MedMatrix in next 12 months and increase those revenues in clinics by 10%.
Proven success in these clinics opens access to hospitals and inpatient services
Expands addressable market from $660B to $2.2T in US alone.
Unique technology and business model allows for rapid commercialization
MedMatrix requires no new administrator training, and no investment in technology switch. The company works with clinics’ existing EHR system. The business model is a rev share model – the company takes a percentage (30-50%) of increase in clinic revenue generated by MedMatrix.
Companies from MedBright’s portfolio across healthcare and technology
2023 Artificial Intelligence
Limmi is a technology company providing a modern AI-powered, HIPAA and FDA compliant data and analysis platform to transform life sciences and healthcare analytics.
2023 Artificial Intelligence
Healthcare Accretion has developed proprietary trained models that harness data quickly and efficiently, providing predictions about patients and facilities that increase revenue and decrease cost, while simultaneously improving patient care and experience.
2022 Healthcare
First Person™ is building the leading brand dedicated to brain health and cognitive performance optimization. First Person’s world first precision-targeted supplement system works to isolate and amplify specific neurotransmitters (Dopamine, Oxytocin, and GABA) around key motor activities: energy, mood, and sleep.
2022 Artificial Intelligence
NetraMark was founded in 2016 by Dr. Joseph Geraci to address the current gaps in the pharmaceutical industry. NetraMark developed proprietary algorithms that can change the way AI is used in this industry. NetraMark developed proprietary algorithms that can change the way AI is used in this industry. NetraAI is a unique machine learning system that provides an intuitive interface for scientists to interact with multimodal datasets to uncover connections related to efficacy, toxicity and placebo response.
Mr. Nathoo is an accomplished businessman having funded and managed various investments in the venture space over the past 30 years. Currently, Mr. Nathoo is Chairman & Chief Executive Officer for Vinergy Capital, Inc. Mr. Nathoo serves as Director of the Company. Mr. Nathoo is principal of a privately held hotel development company which over the past two decades has developed and sold over 10 hotels across Canada.
Michael Dalsin is an industry expert with over 25 years experience specializing in healthcare products, technology and services. Mr. Dalsin was Executive Chairman of Patient Home Monitoring (PHM) and Convalo Health, both Canadian listed healthcare companies, as well as founder and Industry Advisor to The Healthcare Special Opportunity Fund, which is also a listed Canadian company. He has been asked to be a recurring guest lecturer at Yale University Medical School on the topic of fund flows and capital in the global healthcare economy.
Trevor Vieweg is an AI and technology industry expert with 20 years of experience in the field. Mr. Vieweg is a co-founder of Limmi, an AI platform focused on powering the world’s most complex healthcare data analytics systems. He previously served as the Chief Technology Officer of Sea Machines Robotics, a venture backed robotics start-up, as well as Head of Product Development at Viasat. He holds a bachelor’s degree in mechanical & aerospace engineering from Cornell University and a master’s degree in enterprise software architecture from the University of California San Diego.
Mr. Nathoo is an accomplished businessman having funded and managed various investments in the venture space over the past 30 years. Currently, Mr. Nathoo is Chairman & Chief Executive Officer for Vinergy Capital, Inc. Mr. Nathoo serves as Director of the Company. Mr. Nathoo is principal of a privately held hotel development company which over the past two decades has developed and sold over 10 hotels across Canada.
Mr. Balderson has an extensive background in business and has worked in the capital markets for over 20 years. He currently acts as an officer and director of multiple TSX Venture and Canadian Securities Exchange listed companies. Mr. Balderson is the President of Harmony Corporate Services Ltd., a Vancouver based company that provides administrative services to publicly listed companies. Prior to this he was an Investment Advisor with two Canadian investment dealers. Mr. Balderson is a graduate of the Sauder School of Business at the University of British Columbia
Mr. Cherry is a Chartered Accountant and Certified General Accountant with more than 15 years of corporate accounting and audit experience. In his former experience as an auditor, he held positions with KPMG and Davidson and C. LLP in Vancouver. He serves as a Director, CFO and Secretary on several public companies. Mr. Cherry is a CPA having obtained the Chartered Accountant designation in February 2009 and the Certified General Accountant designation in 2004. In his former experience as an auditor, he held positions with KPMG and Davidson and Co. LLP in Vancouver, where he gained experience as an auditor for junior public companies.
Recent News
- MedBright AI Unveils New Investment Presentation Announcing MedMatrix, the AI-Driven Data Analytics and Improvement Platform – November 29, 2023
- MedBright AI Investments and The Ken Sperling Lecture Series Support Medical Economics Lectures at Yale University Medical School – November 22, 2023
- Vinergy Capital Inc. Announces Name Change to MedBright AI Investments Inc. – November 6, 2023
- Vinergy Capital Adds AI Expert to Investment Committee – October 19, 2023
- Vinergy Capital Finalizes Investment in Privately-Backed Healthcare AI Platform Company Adding to its Healthcare AI Portfolio – October 17, 2023
- Vinergy Capital Announces Closing of Non-Brokered Private Placement – October 3, 2023
- Vinergy Provides Update on Healthcare AI Investments and Highlights from New Investor Presentation – September 27, 2023
- Vinergy to Make Investment in Healthcare AI Platform Company to Compliment Recent Investment in Healthcare Trained Model Company; Michael Dalsin to Head Investment Committee – September 8, 2023
- Vinergy Completes Investment in Healthcare Accretion Group – August 30, 2023
Emerging markets Report
Must Read OTC Markets/SEC policy on stock promotion and investor protection
Disclaimer
EMC has been paid $90,000 by MedBright AI Investments Inc. | Please read our full disclaimer
By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact